about
Recommendations for management of equine athletes with cardiovascular abnormalitiesFriesian horses as a possible model for human acquired aortopulmonary fistulation.Atrial fibrillation cycle length and atrial size in horses with and without recurrence of atrial fibrillation after electrical cardioversion.Cardiac troponin I as compared to troponin T for the detection of myocardial damage in horses.Risk factors for recurrence of atrial fibrillation in horses after cardioversion to sinus rhythm.Plasma exchange as a treatment for hyperbilirubinemia in 2 foals with neonatal isoerythrolysis.Atrial Premature Depolarization-Induced Changes in QRS and T Wave Morphology on Resting Electrocardiograms in Horses.Motor evoked potentials in standing and recumbent calves induced by magnetic stimulation at the foramen magnum.Thoracic aortic rupture in horses.Acylcarnitines profile best predicts survival in horses with atypical myopathyHypocalcemia caused by primary hypoparathyroidism in a 3-month-old filly.European outbreaks of atypical myopathy in grazing horses (2006-2009): determination of indicators for risk and prognostic factors.Hospital-based study of dental pathology and faecal particle size distribution in horses with large colon impaction.Two-dimensional speckle tracking for quantification of left ventricular circumferential and radial wall motion in horses.Influence of atrioventricular interaction on mitral valve closure and left ventricular isovolumic contraction measured by tissue Doppler imaging.Noninvasive determination of atrial fibrillation cycle length by atrial colour tissue Doppler imaging in horses.Aortic rupture and aorto-pulmonary fistulation in the Friesian horse: characterisation of the clinical and gross post mortem findings in 24 cases.Cardiovascular responses to transvenous electrical cardioversion of atrial fibrillation in anaesthetized horses.Use of propafenone for conversion of chronic atrial fibrillation in horses.The ECG in cardiovascular-relevant animal models of electrophysiology.Intravenous amiodarone treatment in horses with chronic atrial fibrillation.Total plasma proANP increases with atrial dilatation in horses.Editorial: Atrial fibrillation in horses: new treatment choices for the new millennium?Transvenous electrical cardioversion of atrial fibrillation in six horses using custom made cardioversion catheters.Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.A preliminary study of pulmonary vein implant applicability and safety as a potential ablation platform in a follow-up study in Pigs.3D reconstruction of the porcine and equine pulmonary veins, supplemented with the identification of telocytes in the horse.The Influence of the Size, Age and Sex on the Computed Tomographic Measured Size of the Pituitary Gland in Normal Horses.Echocardiographic measurements of right heart size and function in healthy horses.A Preclinical Study of an Implanted Device in the Pulmonary Veins, Intended for the Treatment of Atrial Fibrillation in an Ovine Model.Right ventricular function during pharmacological and exercise stress testing in horses.European outbreaks of atypical myopathy in grazing equids (2006-2009): spatiotemporal distribution, history and clinical features.Long-term follow-up of atrial function after cardioversion of atrial fibrillation in horses.Heart rate variability parameters in horses distinguish atrial fibrillation from sinus rhythm before and after successful electrical cardioversion.Pharmacokinetics and electrophysiological effects of sotalol hydrochloride in horses.Detection of subclinical left ventricular dysfunction by tissue Doppler imaging in horses with aortic regurgitation.Right ventricular function during acute exacerbation of severe equine asthma.Acute and long-term cardiomyopathy and delayed neurotoxicity after accidental lasalocid poisoning in horses.Tissue Doppler imaging and 2-dimensional speckle tracking of left ventricular function in horses exposed to lasalocid.Influence of detomidine on atrial fibrillation cycle length measured by intracardiac electrogram recording and by colour tissue Doppler imaging in horses.
P50
Q26853142-D7AB0A24-0D4B-44E0-BA3F-9F48FB2B2067Q30376359-E66CB884-8728-4FA2-A250-8D5D6A24745DQ36873418-CA296161-3C3D-47B5-A27D-BB6ED5692C42Q36873596-FAAE07E4-55EE-4A13-BC76-F62A2B34621FQ36974957-9F8E8613-349D-4F15-82D3-FD1013D38A6AQ36975160-E6B0C88E-F038-4F96-8112-7723178B8080Q37384769-2610E626-BAC1-4E0E-BBE0-25579420BA64Q38546384-AFDC54E0-DB3E-4897-A29D-504B292DFB5AQ38991343-4D665A3C-8FB1-4C47-8B38-834E0EB384F5Q41532686-C5C3F99F-178A-421C-A050-7924B39B1C5BQ43183876-12B2C159-63F6-4441-A6DA-B25C54FC7A50Q43341483-C028DE56-E64D-4CC2-8E6B-4935073BA35AQ43531144-CD0602C4-24F9-4E64-A885-AB20A99B1D47Q44178987-01C16760-1FA9-4D6D-BD9B-5CF8F6011666Q44417460-49B4A682-502A-4F2B-A569-68B31760D8D6Q45119972-D8A4027D-7A7C-4AC6-BB07-0BFD460B0535Q45760778-89A3FA06-F1D7-4017-9EC9-C2BEEE9D5DDBQ45963089-1E234528-5499-4366-96BA-A802B8F3BEDAQ46115043-710ADD76-30B2-4D42-A082-06624C38E90EQ46431784-472E6BBE-35F4-4DF8-BA1A-4BC510E5685CQ46502632-98E0644F-9A87-43D8-85FC-F7BD12DFCCAFQ46632631-37A7A22E-5FEA-4D37-9523-CD02B654A92EQ46758433-F482BB05-9724-44FA-A46D-744E011DACF9Q46962521-C4C657DC-632D-4604-A876-92D58F9D10BBQ46967905-D72DCDC9-14F3-48A2-BCFE-50273C64908AQ47189962-94998AE1-8555-4B47-98B7-DE6D808EA5D7Q47191629-9C63F307-8EC5-49CD-A938-8D388F0ED7C6Q47232954-17C1E3D5-6AB2-480C-A894-175C0F5993EDQ47335633-82D082B4-7F5B-48EE-98E8-A8244310F2B6Q47426587-4A86B2CA-6D9D-425C-98C0-C2AA3225D59AQ47653713-D600DD2D-9D42-4143-8E86-BFBCEF6680D7Q47981808-AF47F7C0-5846-48AD-9BC9-812CB336422BQ47993701-522BDC9A-E81D-4264-9EB8-9DB02632B4CCQ48098120-AB035B6B-C392-42A6-B0E6-1641A07D40C6Q48201149-BEDDA457-D8A3-41A0-97C3-891D97E67A88Q48229035-98DBA8C0-16A5-425D-B410-7CCBFE21EC9EQ48575659-331E07E7-F36A-493B-AF3F-6F6E26A127E9Q48694813-5F10CE08-C80C-4228-B586-0B9E779EB526Q48772182-C0E78636-4349-4DF2-9BDA-8C62CF1D8793Q48825114-85E655BC-6706-4581-B75D-986EAC40DF45
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gunther Van Loon
@ast
Gunther Van Loon
@en
Gunther Van Loon
@es
Gunther Van Loon
@nl
Gunther Van Loon
@sl
type
label
Gunther Van Loon
@ast
Gunther Van Loon
@en
Gunther Van Loon
@es
Gunther Van Loon
@nl
Gunther Van Loon
@sl
prefLabel
Gunther Van Loon
@ast
Gunther Van Loon
@en
Gunther Van Loon
@es
Gunther Van Loon
@nl
Gunther Van Loon
@sl
P1053
B-8526-2009
P106
P108
P1153
7006392519
P2038
Gunther_Van_Loon2
P21
P31
P3159
P3829
P3835
gunther-van-loon
P496
0000-0001-5191-5241
P569
1968-01-01T00:00:00Z